Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Faeth Therapeutics, formerly Sensei Biotherapeutics, is a promising player in the oncology sector with its lead asset, PIKTOR, targeting the PI3K/AKT/mTOR pathway. This pathway is...
— Seeking Alpha Contributor
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Faeth Therapeutics
No other institutional pitches found for this ticker yet.